GB2170710B - Improvements relating to pharmaceutical formulations - Google Patents

Improvements relating to pharmaceutical formulations

Info

Publication number
GB2170710B
GB2170710B GB8603031A GB8603031A GB2170710B GB 2170710 B GB2170710 B GB 2170710B GB 8603031 A GB8603031 A GB 8603031A GB 8603031 A GB8603031 A GB 8603031A GB 2170710 B GB2170710 B GB 2170710B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulations
improvements relating
relating
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8603031A
Other versions
GB2170710A (en
GB8603031D0 (en
Inventor
Alan Hilary Calvert
Christine J Rutty
Ian R Judson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
Original Assignee
Institute of Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research filed Critical Institute of Cancer Research
Publication of GB8603031D0 publication Critical patent/GB8603031D0/en
Publication of GB2170710A publication Critical patent/GB2170710A/en
Application granted granted Critical
Publication of GB2170710B publication Critical patent/GB2170710B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
GB8603031A 1985-02-08 1986-02-07 Improvements relating to pharmaceutical formulations Expired GB2170710B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858503221A GB8503221D0 (en) 1985-02-08 1985-02-08 Pharmaceutical formulations

Publications (3)

Publication Number Publication Date
GB8603031D0 GB8603031D0 (en) 1986-03-12
GB2170710A GB2170710A (en) 1986-08-13
GB2170710B true GB2170710B (en) 1989-08-23

Family

ID=10574137

Family Applications (2)

Application Number Title Priority Date Filing Date
GB858503221A Pending GB8503221D0 (en) 1985-02-08 1985-02-08 Pharmaceutical formulations
GB8603031A Expired GB2170710B (en) 1985-02-08 1986-02-07 Improvements relating to pharmaceutical formulations

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB858503221A Pending GB8503221D0 (en) 1985-02-08 1985-02-08 Pharmaceutical formulations

Country Status (1)

Country Link
GB (2) GB8503221D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0419890A3 (en) * 1989-09-29 1991-05-29 American Cyanamid Company Stable pharmaceutical formulations for antineoplastic compounds having more than one ethyleneimine group, and method

Also Published As

Publication number Publication date
GB2170710A (en) 1986-08-13
GB8603031D0 (en) 1986-03-12
GB8503221D0 (en) 1985-03-13

Similar Documents

Publication Publication Date Title
ZA868249B (en) Pharmaceutical preparation
GB2174904B (en) Vasculoprotecting pharmaceutical compositions
GB2171600B (en) Pharmaceutical compositions
GB8602625D0 (en) Pharmaceutical compositions
EP0197752A3 (en) Pharmaceutical compositions
GB8618249D0 (en) Pharmaceutical compositions
GB8515170D0 (en) Pharmaceutical compositions
ZA8667B (en) Pharmaceutical preparation
GB8602602D0 (en) Pharmaceutical compositions
GB8623389D0 (en) Pharmaceutical formulations
GB8607848D0 (en) Pharmaceutical compositions
GB2182561B (en) Pharmaceutical compositions
GB8610970D0 (en) Pharmaceutical compositions
GB2170710B (en) Improvements relating to pharmaceutical formulations
GB8523531D0 (en) Pharmaceutical compositions
GB8602601D0 (en) Pharmaceutical compositions
GB8522327D0 (en) Pharmaceutical compositions
GB8502887D0 (en) Pharmaceutical compositions
GB8608310D0 (en) Pharmaceutical compositions
GB8608309D0 (en) Pharmaceutical compositions
GB8521863D0 (en) Pharmaceutical formulations
GB8524653D0 (en) Pharmaceutical formulations
GB8505297D0 (en) Medicinal compositions
GB8506854D0 (en) Medicinal compositions
GB8522761D0 (en) Pharmaceutical preparation

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee